‘Real World’ pragmatic clinical trials: What are they and what do they tell us?
- 1 February 2002
- journal article
- review article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 13 (1) , 4-9
- https://doi.org/10.1034/j.1399-3038.2002.00194.x
Abstract
Although the explanatory clinical therapeutic trial remains the foundation for assessing drug efficacy and is required for licensing purposes, the overall effectiveness of a treatment can be best judged by carefully designed and well conducted pragmatic 'real world' randomized trials. Pragmatic trials seek to inform prescribers and health care planners on the most effective and cost beneficial treatments. Pragmatic trials deserve more attention and should be included in evidence based guidelines for the pharmacological management of common diseases such as asthma and atopy.Keywords
This publication has 38 references indexed in Scilit:
- Pediatric asthma: ?Real world? measures of effectivenessPediatric Pulmonology, 2001
- Early introduction of inhaled steroids in wheezing children presenting in primary care. A pilot studyClinical and Experimental Allergy, 2000
- Inhaled disodium cromoglycate as maintenance therapy for childhood asthma: time to consign to history?Thorax, 2000
- Licensing of medicinesArchives of Disease in Childhood, 1998
- Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.Archives of Disease in Childhood, 1993
- Pragmatic Versus Explanatory TrialsInternational Journal of Technology Assessment in Health Care, 1989
- A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthmaRespiratory Medicine, 1987
- The Pragmatic Approach to Stroke Trial Design: Stroke Register, Pilot Trial, Assessment of Neurological then Functional OutcomeNeuroepidemiology, 1987
- Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhalerArchives of Disease in Childhood, 1982
- Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen MechanismsNature, 1967